Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dystrophia Myotonica”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03975647
What this trial is testing

Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Seagen, a wholly owned subsidiary of Pfizer 466
Not applicableStudy completedNCT01337141
What this trial is testing

A Telematic Program for Optimization of Metabolic Control in Diabetes Mellitus Type 1 (DM1) Patients

Who this might be right for
Diabetes Mellitus, Type 1Metabolic Disorder
Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders 154
Large-scale testing (Phase 3)Active Not RecruitingNCT06126640
What this trial is testing

A Phase III, Active-Controlled Study of SHR-A1811 Versus Trastuzumab Emtansine (T-DM1) in HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy

Who this might be right for
HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
Jiangsu HengRui Medicine Co., Ltd. 1,615
Testing effectiveness (Phase 2)Study completedNCT01597414
What this trial is testing

Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1

Who this might be right for
Elderly Metastatic Breast Cancer Population
European Organisation for Research and Treatment of Cancer - EORTC 80
Not applicableUnknownNCT00745238
What this trial is testing

Cardiovascular Consequences of NIV Withdrawal in Patients With Myotonic Dystrophy

Who this might be right for
Myotonia
University Hospital, Grenoble 35
Not applicableStudy completedNCT05662150
What this trial is testing

Low-frequency Repetitive Nerve Stimulation in Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
Vrije Universiteit Brussel 9
Not applicableUnknownNCT06029192
What this trial is testing

Diastolic Function in Myotonic Dystrophy Type 1

Who this might be right for
Diastolic Dysfunction
Centre d'Investigation Clinique et Technologique 805 500
Testing effectiveness (Phase 2)Study completedNCT01565200
What this trial is testing

HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1

Who this might be right for
HER-2 Positive Breast Cancer
Jules Bordet Institute 90
Not applicableActive Not RecruitingNCT04656210
What this trial is testing

Myotonic Dystrophy - Vascular and Cognition

Who this might be right for
Myotonic Dystrophy 1DiabetesCarbohydrate Intolerance
University Hospital, Lille 85
Testing effectiveness (Phase 2)Study completedNCT01975142
What this trial is testing

Validity of HER2-amplified Circulating Tumor Cells to Select Metastatic Breast Cancer Considered HER2-negative for Trastuzumab-emtansine (T-DM1) Treatment.

Who this might be right for
Metastatic Breast Cancer, HER2 Negative Primary Tumor
Institut Curie 155
Not applicableUnknownNCT02339402
What this trial is testing

Non Invasive Prenatal Testing (NIPT) of Single-gene Disorders

Who this might be right for
Hereditary Disease
Maastricht University Medical Center 160
Not applicableEnrolling By InvitationNCT06979024
What this trial is testing

A Registered Observational Cohort Study of Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)
First Affiliated Hospital of Fujian Medical University 300
Testing effectiveness (Phase 2)Study completedNCT02657343
What this trial is testing

An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 25
Not applicableEnded earlyNCT03867435
What this trial is testing

Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)

Who this might be right for
Myotonic Dystrophy Type-1Myotonic Dystrophy Type-2
National Institute of Neurological Disorders and Stroke (NINDS) 4
Testing effectiveness (Phase 2)Study completedNCT00679211
What this trial is testing

Trastuzumab-Mcc-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Genentech, Inc. 110
Early research (Phase 1)Study completedNCT02073916
What this trial is testing

T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Jenny C. Chang, MD 24
Not applicableStudy completedNCT03829306
What this trial is testing

Unraveling KAdcyla Resistance In Human Epidermal Growth Factor Receptor 2(HER2) Positive Advanced Breast Cancer (KATIA)

Who this might be right for
Advanced Breast Cancer
Spanish Breast Cancer Research Group 32
Large-scale testing (Phase 3)Active Not RecruitingNCT06265428
What this trial is testing

Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
DualityBio Inc. 228
Not applicableStudy completedNCT02084407
What this trial is testing

Induction of Pluripotent Stem Cells From Human Fibroblasts of DM1 Patients

Who this might be right for
DM1
Institut de Myologie, France 12
Not applicableUnknownNCT02269865
What this trial is testing

Children's Health Research Institute(CHRI), Stanford Lucile Packard Children Hospital (LPCH) Protocol on Myotonic Dystrophy

Who this might be right for
Myotonic Dystrophy Type 1
Stanford University 40
Next Page